Evolutionary Rationale for Phages as Complements of Antibiotics.
暂无分享,去创建一个
[1] Katie Kingwell. Bacteriophage therapies re-enter clinical trials , 2015, Nature Reviews Drug Discovery.
[2] M. Hochberg,et al. Back to the future: evolving bacteriophages to increase their effectiveness against the pathogen Pseudomonas aeruginosa PAO1 , 2013, Evolutionary applications.
[3] J. Laakso,et al. Phage-Driven Loss of Virulence in a Fish Pathogenic Bacterium , 2012, PloS one.
[4] J. Usall,et al. Biopreservative methods to control the growth of foodborne pathogens on fresh-cut lettuce. , 2015, International journal of food microbiology.
[5] R. Müller,et al. Cystobactamids: myxobacterial topoisomerase inhibitors exhibiting potent antibacterial activity. , 2014, Angewandte Chemie.
[6] Franklin L. Nobrega,et al. Revisiting phage therapy: new applications for old resources. , 2015, Trends in microbiology.
[7] C. Townsend,et al. Reconceptualizing synergism and antagonism among multiple stressors , 2015, Ecology and evolution.
[8] B. Shapiro,et al. Evolutionary consequences of intra-patient phage predation on microbial populations , 2014, eLife.
[9] W. Hardt,et al. Antibiotic Treatment Selects for Cooperative Virulence of Salmonella Typhimurium , 2014, Current Biology.
[10] David Laehnemann,et al. When the Most Potent Combination of Antibiotics Selects for the Greatest Bacterial Load: The Smile-Frown Transition , 2013, PLoS biology.
[11] S. Lory,et al. Fitness cost of antibiotic susceptibility during bacterial infection , 2015, Science Translational Medicine.
[12] B. Grenfell,et al. The potential impact of coinfection on antimicrobial chemotherapy and drug resistance. , 2015, Trends in microbiology.
[13] C. Ubeda,et al. Staphylococcal pathogenicity island interference with helper phage reproduction is a paradigm of molecular parasitism , 2012, Proceedings of the National Academy of Sciences.
[14] Mahmoud Y. Alkawareek,et al. Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. , 2012, FEMS immunology and medical microbiology.
[15] R. Donlan,et al. Bacteriophage-Mediated Control of a Two-Species Biofilm Formed by Microorganisms Causing Catheter-Associated Urinary Tract Infections in an In Vitro Urinary Catheter Model , 2014, Antimicrobial Agents and Chemotherapy.
[16] S. Chhibber,et al. Co-Therapy Using Lytic Bacteriophage and Linezolid: Effective Treatment in Eliminating Methicillin Resistant Staphylococcus aureus (MRSA) from Diabetic Foot Infections , 2013, PloS one.
[17] J. Dennis,et al. Burkholderia cepacia Complex Phage-Antibiotic Synergy (PAS): Antibiotics Stimulate Lytic Phage Activity , 2014, Applied and Environmental Microbiology.
[18] A. P. Krueger,et al. OBSERVATIONS ON THE EFFECT OF PENICILLIN ON THE REACTION BETWEEN PHAGE AND STAPHYLOCOCCI , 1948, The Journal of General Physiology.
[19] V. Aleksić,et al. Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa. , 2013, Research in microbiology.
[20] Alexander G. Fletcher,et al. Steering Evolution with Sequential Therapy to Prevent the Emergence of Bacterial Antibiotic Resistance , 2015, PLoS Comput. Biol..
[21] A. Donoghue,et al. Therapeutic efficacy of bacteriophage and Baytril (enrofloxacin) individually and in combination to treat colibacillosis in broilers. , 2004, Poultry science.
[22] Z. Baharoglu,et al. Vibrio cholerae Triggers SOS and Mutagenesis in Response to a Wide Range of Antibiotics: a Route towards Multiresistance , 2011, Antimicrobial Agents and Chemotherapy.
[23] Benjamin S Halpern,et al. Interactive and cumulative effects of multiple human stressors in marine systems. , 2008, Ecology letters.
[24] H. Goossens,et al. Antibiotic resistance—the need for global solutions , 2013, BDJ.
[25] S. Foster,et al. Clonal Expansion during Staphylococcus aureus Infection Dynamics Reveals the Effect of Antibiotic Intervention , 2014, PLoS pathogens.
[26] S. Chhibber,et al. Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment. , 2009, The Journal of antimicrobial chemotherapy.
[27] R. Süssmuth,et al. The gyrase inhibitor albicidin consists of p-aminobenzoic acids and cyanoalanine. , 2015, Nature chemical biology.
[28] J. Pachón,et al. Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like. , 2011, International journal of antimicrobial agents.
[29] M. Loessner,et al. Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application. , 2005, Regulatory toxicology and pharmacology : RTP.
[30] G. Salmond,et al. Exploitation of a new flagellatropic phage of Erwinia for positive selection of bacterial mutants attenuated in plant virulence: towards phage therapy , 2010, Journal of applied microbiology.
[31] M. Hochberg,et al. A Window of Opportunity to Control the Bacterial Pathogen Pseudomonas aeruginosa Combining Antibiotics and Phages , 2014, PloS one.
[32] Puey Ounjai,et al. Phage–host interplay: examples from tailed phages and Gram-negative bacterial pathogens , 2014, Front. Microbiol..
[33] S. Chhibber,et al. Methicillin-Resistant Staphylococcus aureus Phage Plaque Size Enhancement Using Sublethal Concentrations of Antibiotics , 2012, Applied and Environmental Microbiology.
[34] R. P. Ross,et al. Phage therapy in the food industry. , 2014, Annual review of food science and technology.
[35] Troy Day,et al. The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy , 2011, Proceedings of the National Academy of Sciences.
[36] S. Scheu,et al. Predators promote defence of rhizosphere bacterial populations by selective feeding on non-toxic cheaters , 2009, The ISME Journal.
[37] Christian Melander,et al. Combination approaches to combat multidrug-resistant bacteria. , 2013, Trends in biotechnology.
[38] Troy Day,et al. The path of least resistance: aggressive or moderate treatment? , 2014, Proceedings of the Royal Society B: Biological Sciences.
[39] I. Okeke. Poverty and Root Causes of Resistance in Developing Countries , 2010 .
[40] P. Volberding,et al. Antiretroviral therapy and management of HIV infection , 2010, The Lancet.
[41] E. Änggård,et al. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacy , 2009, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[42] M. Kutateladze,et al. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. , 2010, Trends in biotechnology.
[43] J. Duval,et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. , 1988, The New England journal of medicine.
[44] N. Chanishvili. Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches. , 2012, Advances in virus research.
[45] Timothy K Lu,et al. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy , 2009, Proceedings of the National Academy of Sciences.
[46] S. Reardon. Antibiotic resistance sweeping developing world , 2014, Nature.
[47] Daniel Kalman,et al. Aligning antimicrobial drug discovery with complex and redundant host-pathogen interactions. , 2009, Cell host & microbe.
[48] Paul S Mischel,et al. A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments. , 2013, Carcinogenesis.
[49] A. Kirby. Synergistic Action of Gentamicin and Bacteriophage in a Continuous Culture Population of Staphylococcus aureus , 2012, PloS one.
[50] B. Brunelle,et al. Fluoroquinolone induction of phage-mediated gene transfer in multidrug-resistant Salmonella. , 2015, International journal of antimicrobial agents.
[51] M. Winterhalter,et al. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria , 2008, Nature Reviews Microbiology.
[52] K. Lewis,et al. A new antibiotic kills pathogens without detectable resistance , 2015, Nature.
[53] S. West,et al. Cooperation, Quorum Sensing, and Evolution of Virulence in Staphylococcus aureus , 2013, Infection and Immunity.
[54] A. Buckling,et al. Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms , 2012, Evolutionary applications.
[55] G. Bou,et al. Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World? , 2013, Clinical Microbiology Reviews.
[56] J. Bull,et al. Population and evolutionary dynamics of phage therapy , 2004, Nature Reviews Microbiology.
[57] H. Krisch,et al. Phage-Antibiotic Synergy (PAS): β-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth , 2007, PloS one.
[58] J. Gill,et al. Phage therapy redux—What is to be done? , 2015, Science.
[59] M. Santamaría,et al. Main features on tailed phage, host recognition and DNA uptake. , 2004, Frontiers in bioscience : a journal and virtual library.